Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in mice
- 1 September 2007
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 571 (1) , 72-80
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Matrix metalloproteinase‐3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injuryJournal of Neuroscience Research, 2006
- Microbial Antigen Triggers Rapid Mobilization of TNF-α to the Surface of Mouse Neutrophils Transforming Them into Inducers of High-Level Dendritic Cell TNF-α ProductionThe Journal of Immunology, 2005
- Angiostatin and matrix metalloprotease expression following ischemic acute renal failureAmerican Journal of Physiology-Renal Physiology, 2004
- TNF-α antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbitsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Shedding of interleukin‐6 receptor and tumor necrosis factor αEuropean Journal of Biochemistry, 2000
- Matrix Metalloproteinase-2 Contributes to Ischemia-Reperfusion Injury in the HeartCirculation, 2000
- Pathophysiology of ischaemia-reperfusion injuryThe Journal of Pathology, 2000
- TUMOR NECROSIS FACTOR UP-REGULATES INTERCELLULAR ADHESION MOLECULE 1, WHICH IS IMPORTANT IN THE NEUTROPHIL-DEPENDENT LUNG AND LIVER INJURY ASSOCIATED WITH HEPATIC ISCHEMIA AND REPERFUSION IN THE RATShock, 1998
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cellsNature, 1997
- Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding.Proceedings of the National Academy of Sciences, 1996